In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Chemours Company (NYSE: CC) closed at $16.49 in the last session, down -3.11% from day before closing price of $17.02. In other words, the price has decreased by -$3.11 from its previous closing price. On the day, 2.76 million shares were traded. CC stock price reached its highest trading level at $17.4799 during the session, while it also had its lowest trading level at $16.44.
Ratios:
We take a closer look at CC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.68. In the meantime, Its Debt-to-Equity ratio is 18.59 whereas as Long-Term Debt/Eq ratio is at 18.18.
On January 28, 2025, Truist started tracking the stock assigning a Buy rating and target price of $27. UBS Upgraded its Neutral to Buy on July 09, 2024, whereas the target price for the stock was revised from $28 to $30.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 08 ’25 when Dignam Denise bought 4,068 shares for $12.06 per share. The transaction valued at 49,060 led to the insider holds 191,546 shares of the business.
Gumpel Damian bought 13,400 shares of CC for $123,548 on Jun 02 ’25. The insider now owns 123,879 shares after completing the transaction at $9.22 per share. On Jun 03 ’25, another insider, Gumpel Damian, who serves as the insider of the company, bought 7,822 shares for $9.95 each. As a result, the insider paid 77,828 and bolstered with 131,701 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CC now has a Market Capitalization of 2468525056 and an Enterprise Value of 6379525120. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 10.42. Its current Enterprise Value per Revenue stands at 1.091 whereas that against EBITDA is 9.608.
Stock Price History:
The Beta on a monthly basis for CC is 1.65, which has changed by -0.117709994 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, CC has reached a high of $22.38, while it has fallen to a 52-week low of $9.13. The 50-Day Moving Average of the stock is 12.89%, while the 200-Day Moving Average is calculated to be 13.67%.
Shares Statistics:
According to the various share statistics, CC traded on average about 4.19M shares per day over the past 3-months and 3137520 shares per day over the past 10 days. A total of 149.70M shares are outstanding, with a floating share count of 148.58M. Insiders hold about 0.75% of the company’s shares, while institutions hold 100.63% stake in the company. Shares short for CC as of 1756425600 were 15010599 with a Short Ratio of 3.58, compared to 1753920000 on 14870588. Therefore, it implies a Short% of Shares Outstanding of 15010599 and a Short% of Float of 14.739999000000001.
Dividends & Splits
The forward annual dividend rate for CC is 0.68, which was 0.838 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.04923619. The stock’s 5-year Average Dividend Yield is 4.07.
Earnings Estimates
The dynamic stock of Chemours Company (CC) is currently attracting attention from 7.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.25, with high estimates of $0.31 and low estimates of $0.18.
Analysts are recommending an EPS of between $1.5 and $1.12 for the fiscal current year, implying an average EPS of $1.23. EPS for the following year is $2.12, with 9.0 analysts recommending between $2.58 and $1.46.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $1.5B. It ranges from a high estimate of $1.53B to a low estimate of $1.42B. As of the current estimate, Chemours Company’s year-ago sales were $1.5BFor the next quarter, 7 analysts are estimating revenue of $1.4B. There is a high estimate of $1.43B for the next quarter, whereas the lowest estimate is $1.39B.
A total of 9 analysts have provided revenue estimates for CC’s current fiscal year. The highest revenue estimate was $5.95B, while the lowest revenue estimate was $5.8B, resulting in an average revenue estimate of $5.9B. In the same quarter a year ago, actual revenue was $5.78BBased on 9 analysts’ estimates, the company’s revenue will be $6.17B in the next fiscal year. The high estimate is $6.27B and the low estimate is $6.06B.
